Literature DB >> 1102165

Surface markers on lymphocytes of multiple sclerosis patients.

J Nowak, A Wajgt.   

Abstract

Peripheral blood lymphocytes of twenty-two multiple sclerosis (MS) patients and thirty-five healthy controls were examined for the presence of surface markers characteristic for B lymphocytes (surface immunoglobulin, receptor for C3 (EAC), reporter for Fc (EA) and the spontaneous rosette-forming capacity characteristic of T cells. The results obtained indicate that the number of B and T cells in MS is similar to controls, as evaluated by the presence of surface immunoglobulin and E rosette-forming capacity. However, a statistically significant reduction in the percentage of lymphocytes bearing C3 receptors has been found in MS patients. It might have resulted from a reduction in the lymphocyte population bearing C3 receptor but no surface immunoglobulin. The EA rosette test revealed the greatest difference between the groups. The difference indicated a reduction in the density of the receptor for 7S Fc on lymphocytes from MS patients. The results obtained are consistent with the hypothesis of an immune deficit in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1102165      PMCID: PMC1538277     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Measles antibodies in multiple sclerosis.

Authors:  J M ADAMS; D T IMAGAWA
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

Review 2.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

3.  Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  P Brown; F Cathala; D C Gajdusek; C J Gibbs
Journal:  Proc Soc Exp Biol Med       Date:  1971-07

4.  [Correlation between protein changes in the cerebrospinal fluid and the level of measles antibodies in patients with multiple sclerosis].

Authors:  A Wajgt; E Bogaczyńska; B Zgorzalewicz
Journal:  Neurol Neurochir Pol       Date:  1974 Sep-Oct       Impact factor: 1.621

5.  Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen.

Authors:  H Wigzell; K G Sundqvist; T O Yoshida
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

6.  Surface markers on lymphocytes of patients with infectious diseases.

Authors:  F Aiuti; M V Ciarla; C D'Asero; R D'Amelio; J A Garofalo
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

7.  Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes.

Authors:  G D Ross; E M Rabellino; M J Polley; H M Grey
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

8.  Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin.

Authors:  E R Unanue; H M Grey; E Rabellino; P Campbell; J Schmidtke
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

9.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  2 in total

1.  A 'profile' of immune responsiveness in multiple sclerosis.

Authors:  G R Symington; I R Mackay; S Whittingham; J White; J D Buckley
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

2.  Tests on peripheral blood cells in multiple sclerosis.

Authors:  S McCrea; M Killen; J Thompson; W A Fleming; T A McNeill; J H Millar
Journal:  Ulster Med J       Date:  1979
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.